Liver Fibrosis Helps to Distinguish Autoimmune Hepatitis from DILI with Autoimmune Features: A Review of Twenty Cases
Open Access
- 9 January 2019
- journal article
- review article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 7 (X), 1-6
- https://doi.org/10.14218/jcth.2018.00053
Abstract
Background and Aims: Drug-induced liver injury with autoimmune features (AI-DILI) mimics the clinical presentation, and laboratory and pathologic features of idiopathic autoimmune hepatitis (AIH). We aimed to identify histopathologic hallmarks to differentiate these entities.Keywords
This publication has 15 references indexed in Scilit:
- Cellular and Molecular Mechanisms of Autoimmune HepatitisAnnual review of pathology, 2018
- Features of Autoimmune Hepatitis in Patients With Drug-induced Liver InjuryClinical Gastroenterology and Hepatology, 2016
- Drug-Induced Liver Injury with Autoimmune FeaturesSeminars in Liver Disease, 2014
- Drug-Induced Autoimmune-Like Hepatitis: A Case of Chronic Course After Drug WithdrawalDigestive Diseases and Sciences, 2011
- The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injuryJournal of Hepatology, 2011
- Drug-Induced Autoimmune-Like HepatitisDigestive Diseases and Sciences, 2011
- Diagnosis and management of autoimmune hepatitisJournal of Hepatology, 2010
- Autoantibodies in chronic liver disease.2005
- Quantification of histochemical staining by color deconvolution.2001
- Classification of chronic viral hepatitis: a need for reassessmentJournal of Hepatology, 1991